JOSÉ JOAQUÍN
PORTU ZAPIRAIN
Hospital Universitario Central de Asturias
Oviedo, EspañaPublications in collaboration with researchers from Hospital Universitario Central de Asturias (6)
2015
-
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program
Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480
2012
-
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial
Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968
2010
-
Factores asociados con la no realización de la prueba de la tuberculina en una cohorte de pacientes VIH positivos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 4, pp. 215-221
2009
-
Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
BMC Infectious Diseases, Vol. 10
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2007
-
Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: Early prediction of sustained virological response rate
Alimentary Pharmacology and Therapeutics, Vol. 25, Núm. 8, pp. 899-906